Page last updated: 2024-10-21

ag-1549 and Diarrhea

ag-1549 has been researched along with Diarrhea in 1 studies

capravirine: a non-nucleoside reverse transcriptase inhibitor

Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gewurz, BE1
Jacobs, M1
Proper, JA1
Dahl, TA1
Fujiwara, T1
Dezube, BJ1

Trials

1 trial available for ag-1549 and Diarrhea

ArticleYear
Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.
    The Journal of infectious diseases, 2004, Dec-01, Volume: 190, Issue:11

    Topics: Administration, Oral; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Female; HIV Infections; HIV-1

2004